SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2v9q'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A7Y_A_DVAA8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.70A 1a7yA-2v9qA:
undetectable
1a7yA-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A7Y_B_DVAB2_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.89A 1a7yB-2v9qA:
undetectable
1a7yB-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A7Y_B_DVAB8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.76A 1a7yB-2v9qA:
undetectable
1a7yB-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DSC_C_DVAC8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.82A 1dscC-2v9qA:
undetectable
1dscC-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FJA_C_DVAC8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.83A 1fjaC-2v9qA:
undetectable
1fjaC-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FJA_D_DVAD8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.84A 1fjaD-2v9qA:
undetectable
1fjaD-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I3W_E_DVAE2_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.74A 1i3wE-2v9qA:
undetectable
1i3wE-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I3W_E_DVAE8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.73A 1i3wE-2v9qA:
undetectable
1i3wE-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I3W_F_DVAF8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.73A 1i3wF-2v9qA:
undetectable
1i3wF-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I3W_G_DVAG2_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.75A 1i3wG-2v9qA:
undetectable
1i3wG-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I3W_G_DVAG8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.78A 1i3wG-2v9qA:
undetectable
1i3wG-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I3W_H_DVAH8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.76A 1i3wH-2v9qA:
undetectable
1i3wH-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MNV_D_DVAD2_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.75A 1mnvD-2v9qA:
undetectable
1mnvD-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MNV_D_DVAD8_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.70A 1mnvD-2v9qA:
undetectable
1mnvD-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OVF_B_DVAB2_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.74A 1ovfB-2v9qA:
undetectable
1ovfB-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QFI_A_DVAA8_0
(ACTINOMYCIN X2)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.69A 1qfiA-2v9qA:
undetectable
1qfiA-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QFI_B_DVAB8_0
(ACTINOMYCIN X2)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.73A 1qfiB-2v9qA:
undetectable
1qfiB-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_F_DVAF2_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.77A 1unjF-2v9qA:
undetectable
1unjF-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_F_DVAF8_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.75A 1unjF-2v9qA:
undetectable
1unjF-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_L_DVAL2_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.78A 1unjL-2v9qA:
undetectable
1unjL-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_L_DVAL8_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.73A 1unjL-2v9qA:
undetectable
1unjL-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_R_DVAR2_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.78A 1unjR-2v9qA:
undetectable
1unjR-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_R_DVAR8_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.75A 1unjR-2v9qA:
undetectable
1unjR-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_W_DVAW8_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.74A 1unjW-2v9qA:
undetectable
1unjW-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_X_DVAX2_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.76A 1unjX-2v9qA:
undetectable
1unjX-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNJ_X_DVAX8_0
(7-AMINO-ACTINOMYCIN
D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.73A 1unjX-2v9qA:
undetectable
1unjX-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNM_E_DVAE2_0
(7-AMINOACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.76A 1unmE-2v9qA:
undetectable
1unmE-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNM_E_DVAE8_0
(7-AMINOACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.73A 1unmE-2v9qA:
undetectable
1unmE-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNM_F_DVAF2_0
(7-AMINOACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.78A 1unmF-2v9qA:
undetectable
1unmF-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UNM_F_DVAF8_0
(7-AMINOACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 228
THR A 230
PRO A 186
None
0.76A 1unmF-2v9qA:
undetectable
1unmF-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD2_A_CHDA2_0
(FERROCHELATASE)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
4 / 8 LEU A 211
PRO A 176
SER A 251
VAL A 179
None
0.92A 2qd2A-2v9qA:
undetectable
2qd2A-2v9qA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QEI_A_CXXA802_1
(TRANSPORTER)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
4 / 6 SER A 117
ARG A 131
PHE A 129
ILE A 132
None
1.19A 2qeiA-2v9qA:
undetectable
2qeiA-2v9qA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IAZ_A_AINA1202_1
(LACTOTRANSFERRIN)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 GLU A 250
GLY A 242
THR A 243
None
0.58A 3iazA-2v9qA:
undetectable
3iazA-2v9qA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9K_A_CAMA424_0
(CYTOCHROME P450)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
5 / 9 THR A 110
THR A  86
LEU A 121
LEU A 122
GLY A 125
None
1.38A 4c9kA-2v9qA:
undetectable
4c9kA-2v9qA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9P_A_CAMA423_0
(CYTOCHROME P450)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
5 / 9 THR A 110
THR A  86
LEU A 121
LEU A 122
GLY A 125
None
1.39A 4c9pA-2v9qA:
undetectable
4c9pA-2v9qA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HIV_D_DVAD2_0
(ACTINOMYCIN D)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
3 / 3 THR A 230
PRO A 186
THR A 228
None
0.80A 4hivD-2v9qA:
undetectable
4hivD-2v9qA:
10.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KLR_A_CHDA504_0
(FERROCHELATASE,
MITOCHONDRIAL)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
4 / 7 LEU A 211
PRO A 176
SER A 251
VAL A 179
None
0.99A 4klrA-2v9qA:
undetectable
4klrA-2v9qA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_C_STRC601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
4 / 5 ILE A  78
ASP A 141
GLU A 164
VAL A 246
None
1.20A 4nkxC-2v9qA:
undetectable
4nkxC-2v9qA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_D_STRD601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2v9q ROUNDABOUT HOMOLOG 1
(Homo
sapiens)
4 / 5 ILE A  78
ASP A 141
GLU A 164
VAL A 246
None
1.26A 4nkxD-2v9qA:
undetectable
4nkxD-2v9qA:
17.25